OSE Pharma SA (OSE) - Total Liabilities

Latest as of June 2025: €53.58 Million EUR ≈ $62.64 Million USD

Based on the latest financial reports, OSE Pharma SA (OSE) has total liabilities worth €53.58 Million EUR (≈ $62.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore OSE net assets growth trend to track the company's year-over-year net asset growth rate.

OSE Pharma SA - Total Liabilities Trend (2012–2024)

This chart illustrates how OSE Pharma SA's total liabilities have evolved over time, based on quarterly financial data. See OSE Pharma SA free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

OSE Pharma SA Competitors by Total Liabilities

The table below lists competitors of OSE Pharma SA ranked by their total liabilities.

Company	Country	Total Liabilities
Centrica PLC LSE:CNA	UK	GBX11.92 Billion
Hanjin Heavy Ind & Const Holdings Co Ltd KO:003480	Korea	₩1.21 Trillion
Viet Nam Power Development JSC VN:VPD	Vietnam	₫93.86 Billion
Samsung Pharm KO:001360	Korea	₩44.04 Billion
Hwaseung Industries Co Ltd KO:006060	Korea	₩1.09 Trillion
Netbay Public Company Limited BK:NETBAY	Thailand	฿201.59 Million
Guru Organic Energy Corp TO:GURU	Canada	CA$9.29 Million
Immutep Ltd ADR NASDAQ:IMMP	USA	$48.30 Million

Liability Composition Analysis (2012–2024)

This chart breaks down OSE Pharma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OSE Pharma SA (OSE) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.74	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OSE Pharma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OSE Pharma SA (2012–2024)

The table below shows the annual total liabilities of OSE Pharma SA from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	€60.15 Million ≈ $70.32 Million	+1.81%
2023-12-31	€59.08 Million ≈ $69.07 Million	-0.07%
2022-12-31	€59.12 Million ≈ $69.12 Million	+9.52%
2021-12-31	€53.99 Million ≈ $63.12 Million	+51.61%
2020-12-31	€35.61 Million ≈ $41.63 Million	+17.15%
2019-12-31	€30.40 Million ≈ $35.54 Million	+100.65%
2018-12-31	€15.15 Million ≈ $17.71 Million	-30.85%
2017-12-31	€21.91 Million ≈ $25.61 Million	-12.45%
2016-12-31	€25.02 Million ≈ $29.25 Million	+893.33%
2015-12-31	€2.52 Million ≈ $2.94 Million	-9.49%
2014-12-31	€2.78 Million ≈ $3.25 Million	+131.92%
2013-12-31	€1.20 Million ≈ $1.40 Million	+31.15%
2012-12-31	€915.00K ≈ $1.07 Million	--

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$84.19 Million

€72.01 Million EUR

Market Cap Rank

#19795 Global

#302 in France

Share Price

€3.21

Change (1 day)

+1.65%

52-Week Range

€3.02 - €7.20

All Time High

€15.00